PolicyLatest
Pharmalittle: Trump tariffs and Lilly obesity pill news
Trump's tariff plans are under scrutiny as they may impact the pharmaceutical industry. Additionally, the FDA has approved a new obesity pill from Lilly, marking a significant development in weight management treatments.
0 upvotes
What happened
Trump's tariff plans are under scrutiny as they may impact the pharmaceutical industry.
Why it matters
Additionally, the FDA has approved a new obesity pill from Lilly, marking a significant development in weight management treatments.